Navigation Links
Avreo Previews Version 7 RIS/PACS at RSNA
Date:11/27/2011

CHARLESTON, S.C., Nov. 27, 2011 /PRNewswire/ -- As a leader in unified RIS/PACS, Avreo continues to reinvent radiology workflow with its Version 7 release for preview at RSNA.  Version 7 represents an extensive platform change to support key areas of growth including:

  • All new modern design with focus on workflow and usability within radiology and meaningful use.
  • Cross-platform support, including Windows®, Mac OS® X, Apple® iOS, and Android™, to facilitate communication and information exchange, while embracing healthcare professionals' preferred tools. 
  • Advanced business reporting and dashboard visualization to identify trends so your organization can respond with actionable changes.

John Ciccarelli, Avreo Vice President of Sales and Marketing states, "While everyone raced to provide iPad functionality for referring physicians, we took the next step to provide Cross Platform connectivity."  Jonah Still, Avreo Chief Technology Officer continued "These advancements are really important for our customers as they improve usability and direct focus to clinical information while establishing a modern, fresh appearance."

Healthcare organizations can preview these and other Version 7 innovations at RSNA 2011 in Avreo booth 5423, Hall A. 

About Avreo

Avreo, founded in 1997, is a leading provider of Radiology Workflow Solutions for outpatient facilities, multi-specialty organizations, community hospitals, radiology groups, and orthopedic practices.  Our family of innovative solutions combines services from RIS, PACS, Dictation, Transcription, and Automatic Report Distribution within a single application, single database solution to encompass all the features a busy practice or hospital needs to operate efficiently.  Avreo is a privately held company based in Charleston, SC.  Avreo offers solutions on an operational (fee/exam) or capital acquisition payment model.  For more information, visit www.avreo.com or call 1-800-844-9926.


'/>"/>
SOURCE Avreo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
2. Misonix Previews New OsteoSculpt® Ultrasonic Bone Scalpel
3. Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference
4. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
7. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
8. Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
9. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
10. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
11. VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
(Date:4/26/2016)... , April 26, 2016 Diplomat Pharmacy, ... of Jennifer Hagerman , Pharm D., to Vice ... growing role at Diplomat, Hagerman will continue to lead ... company that delivers custom education and training to Diplomat ... specialty pharmacy industry. Diplomat University also houses the quality ...
(Date:4/26/2016)... , April 26, 2016 Research ... and Credit Risk Analysis of the Biological Medicine Industry ... This comprehensive report analyzes the financial assessment and credit ... China . The report provides readers with an ... all market participants should be aware of. It considers ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... 2016 , ... One way to ignore solid evidence is to dismiss research ... toss the baby out with the bathwater when we ignore all studies because some ... and otherwise making better use of education policy research. , “When readers heed basic ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... USA Medical Card reminds us that May ... (CDC), a stroke is the fourth leading cause of death in the United States; someone ... almost a quarter of them in individuals under 65 years old. A stroke is ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... today announced a new Residency Education & Collaboration Platform for hospitals and ... resources, and a host of collaboration tools designed to improve patient outcomes ...
(Date:4/28/2016)... ... 2016 , ... A first-time look at workers’ compensation claims in Kentucky found ... Compensation Research Institute (WCRI) announced, and that costs per claim were stable between ... Edition , found that indemnity costs per claim and benefit delivery expenses per claim ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... has partnered with Community Oncology Pharmacy Association (COPA) to develop a comprehensive Specialty ... of oncology by introducing an accreditation distinction. ACHC provides a wide range of ...
Breaking Medicine News(10 mins):